Company page
Read-gene Sa
Read-gene SA is a public company listed on the Polish market under the ticker RDG, with a market capitalization of approximately 16.5 million. The company focuses on advancements in genetic research and technology. Its operations aim to contribute to the growing field of genomics and personalized medicine.

- Ticker
- RDG:NEWCONNECT
- Asset type
- Stock
- Market cap
- $16.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NEWCONNECT
- Currency
- PLN